ACM
DERM icon

Aster Capital Management’s Journey Medical DERM Stock Holding History

Aster Capital Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Buy
+30,720
New +$175K 0.05% 396

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Aster Capital Management's DERM Position: Q2 2026 in Review

Aster Capital Management opened a new position in Journey Medical (DERM) in Q2 2026: 30,720 shares worth $217K. The stake represents 0.05% of the portfolio and ranks #396 among its holdings.

71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Aster Capital Management held 30,720 shares of Journey Medical worth $217K as of Q2 2026.
  • Journey Medical was a new Aster Capital Management position in Q2 2026.
  • Journey Medical made up 0.05% of Aster Capital Management's portfolio in Q2 2026, its #396 holding.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.